Harlan W. Waksal
2019 - Kadmon Holdings
In 2019, Harlan W. Waksal earned a total compensation of $4.7M as President and Chief Executive Officer at Kadmon Holdings, a 27% increase compared to previous year.
Compensation breakdown
| Bonus | $500,000 |
|---|---|
| Option Awards | $3,727,482 |
| Salary | $500,000 |
| Other | $15,285 |
| Total | $4,742,767 |
Waksal received $3.7M in option awards, accounting for 79% of the total pay in 2019.
Waksal also received $500K in bonus, $500K in salary and $15.3K in other compensation.
Rankings
In 2019, Harlan W. Waksal's compensation ranked 2,372nd out of 13,971 executives tracked by ExecPay. In other words, Waksal earned more than 83.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,372 out of 13,971 | 83rd |
Division Manufacturing | 858 out of 5,701 | 85th |
Major group Chemicals And Allied Products | 276 out of 2,200 | 88th |
Industry group Drugs | 221 out of 1,886 | 88th |
Industry Pharmaceutical Preparations | 162 out of 1,398 | 88th |
Source: SEC filing on April 2, 2020.
Waksal's colleagues
We found two more compensation records of executives who worked with Harlan W. Waksal at Kadmon Holdings in 2019.
News
Lyra Therapeutics Chairman Harlan Waksal receives $5M in 2022
April 25, 2023
Kadmon Holdings CFO Steven Meehan's 2020 pay jumps 76% to $2.3M
April 1, 2021
Kadmon Holdings CEO Harlan Waksal's 2019 pay jumps 27% to $4.7M
April 2, 2020
Kadmon Holdings CEO Harlan Waksal's 2018 pay jumps 43% to $3.7M
April 2, 2019